Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
10000 participants
OBSERVATIONAL
2020-07-08
2030-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Real World Study on the Efficacy and Safety of Apremilast in Chinese Patients With Moderate to Severe Plaque Psoriasis, a Multi Center, Prospective, Observational Trial（REACT）
NCT05863273
A Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China
NCT03236870
A Phase 3 Study of Efficacy and Safety of AK101 in Subjects With Psoriasis
NCT05120297
A Prospective Multicenter Study for the Assessment of Treatment Patterns, Effectiveness and Safety of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis in a Real-world Setting in China
NCT04894890
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea
NCT04167462
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study is an observational, multi-centre study based on real-world evidence. Inclusion criteria is the patients who visit the clinic diagnosed psoriasis by the dermatologist. There existed no exclusion criteria. Information were most collected by a phone application called "Psoriasis New World".
Primary outcome measure is the percentage of patients who achieved a PASI reduction of 100% (PASI 100). And Psoriasis Area and Severity Index includes scores of erythema, infiltration and desquamation, weighted by area of involvement in each regions (head and neck, upper extremities, trunk, lower extremities), with higher PASI scores indicating worse condition. Also, static Physician Global Assessment (sPGA), static Investigator Global Assessment (sIGA), Body surface area (BSA) and Dermatology Life Quality Index (DLQI) are measured to assess the severity of psoriasis and the change of the disease condition. It is important to monitor all the Adverse Events (AEs) over the whole study. In addition, the laboratory examinations of patients such as liver function are also collected.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Psoriasis
This is a non-interventional study (NIS). All the patients diagnosed as psoriasis by the dermatologists in the clinic are included in this study no matter what kind of treatment they adopt.
NIS
This is a non-interventional study (NIS).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NIS
This is a non-interventional study (NIS).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiaoyong Man
Principal Investigator, Head of Dermatology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
Beijing Children's Hospital Affiliated to Capital Medical University
Beijing, , China
the First Affiliated Hospital of Chongqing Medical University
Chongqing, , China
the First Affiliated Hospital of Fujian Medical University
Fujian, , China
General Hospital of Lanzhou Military Region
Gansu, , China
Sun Yat-sen Memorial Hospital
Guangdong, , China
The Peoples' Hospital of Guangxi Zhuang Autonomous Region
Guangxi, , China
the Affiliated Hospital of Guizhou Medical University
Guizhou, , China
The Fifth People's Hospital of Hainan Province
Hainan, , China
the First Hospital of Hebei Medical University
Hebei, , China
the Second Affiliated Hospital of Harbin Medical Unviersity
Heilongjiang, , China
Henan Provincial Peoples' Hospital
Henan, , China
the Affiliated Hospital of Inner Mongolia Medical University
Hohhot, , China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Hubei, , China
Xiangya Hospital, Central South University
Hunan, , China
the Second Affiliated Hospital of Nanchang University
Jiangxi, , China
Yanbian University Hospital
Jilin, , China
Institute of Dermatology, Chinese Academy of Medical Sciences
Nanjing, , China
Xining First Hospital
Qinghai, , China
Shandong Provincial Hospital for Skin Diseases
Shandong, , China
Shanghai Dermatology Hospital
Shanghai, , China
Taiyuan Central Hospital
Shanxi, , China
the Second Affiliated Hospital of Xi'an Jiaotong University
Shanxi, , China
the First hospital of China Medical University
Shenyang, , China
Sichuan Provincial People's Hospital
Sichuan, , China
Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital
Tianjin, , China
First Affiliated Hospital, School of Medicine, Shihezi University
Xinjiang, , China
General Hospital of Ningxia Medical University
Yinchuan, , China
the Second Affiliated Hospital of Kunming Medical University
Yunnan, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-354
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.